The IoT Medical Devices Market was valued at USD 43.38 billion in 2023 and is valued at USD 57.31 billion in 2024, with a projected value of USD 541.21 billion by 2032. Polaris Market Research forecasts a CAGR of 32.40% during the forecast period 2024–2032, with 2023 as the base year. Leading players include Abbott Laboratories, AliveCor, Inc., Baxter International Inc., BIOTRONIK, Boston Scientific Corporation, Drägerwerk AG & Co. KGaA, GE Healthcare, Honeywell Life Care Solutions, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Masimo, Medtronic, Omron Healthcare, Inc., ResMed, and Siemens AG.
Hospitals and Clinics Lead End-User Adoption in the IoT Medical Devices Market
By end user, the market is segmented into hospitals and clinics, nursing home and care centers, and others. The hospitals and clinics segment accounted for a significant revenue share in 2022. Connected devices enable uninterrupted tracking of heart rate, blood pressure, and oxygen levels, with data transmitted swiftly to professionals so they can intervene immediately and reduce the need for constant bedside monitoring.
Facilities also use IoT technology to track the location and status of equipment such as infusion pumps, wheelchairs, and diagnostic devices, which optimizes utilization, minimizes losses, and ensures availability. Tracking the movement of patients and staff aids workflow optimization, reduces congestion in waiting areas, and enhances patient experience. IoT devices have also been used to oversee and optimize the supply chain for critical medical equipment.
Implantable Medical Devices and Device Miniaturization
Implantable medical devices form one of the report's four type categories alongside wearable, stationary, and other devices. Ongoing advances in sensor technology, wireless connectivity, and data analytics have made it increasingly feasible to develop and deploy connected devices, elevating precision, dependability, and affordability. Sensor technology has also enabled the remarkable downsizing of devices, supporting continuous monitoring without inconvenience to patients.
In April 2023, Honeywell introduced a real-time health monitoring system that monitors patients' vital signs in the hospital and remotely, using advanced sensing technology that captures vital signs through a skin patch.
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/iot-medical-devices-market
Connectivity: Wi-Fi Leads the Technology Segment
By technology, the market covers Bluetooth, Wi-Fi, ZigBee, and others. Wi-Fi emerged as the largest segment in 2022. Wearable health trackers and vital sign monitors can connect to Wi-Fi networks to relay real-time patient data to providers, which is valuable for individuals managing chronic ailments such as diabetes, cardiovascular conditions, or hypertension. Wi-Fi-equipped smart medication dispensers and adherence aids send reminders and alerts to patients, caregivers, or providers, supporting consistent adherence to prescribed medications.
Chronic Disease Prevalence and Aging Populations
The prevalence of chronic diseases such as diabetes, cardiovascular issues, and respiratory ailments has accelerated demand for continuous monitoring, giving patients real-time data on vital signs and relevant biomarkers to manage their conditions. The global aging population has intensified the requirement for healthcare services, and connected devices help deliver efficient, cost-effective care for senior citizens, enabling them to age in place while being monitored remotely. Alongside telehealth services, these trends are expected to sustain demand.
Global health crises, including COVID-19, have raised the importance of early detection, and connected devices have been enlisted for surveillance and rapid response efforts.
Competitive Landscape
The IoT Medical Devices market is fragmented, with numerous players launching innovative products to strengthen their positions. Participants focus on partnerships, product enhancements, and collaborative efforts to gain a competitive advantage. North America was the largest region in 2022, operating within a defined regulatory framework in which the FDA plays a critical role.
In May 2023, Medtronic plc announced the acquisition of EOFlow Co. Ltd. to enhance its diabetes portfolio, combining its Meal Detection Technology algorithm and a next-generation continuous glucose monitor with the EOPatch device, a tubeless, wearable, fully disposable insulin delivery device. High implementation costs are cited among market restraints.
More Trending Latest Reports By Polaris Market Research:
Gynecological Examination Chairs Market
Enterprise Content Management Market
AI Trust, Risk and Security Management Market